Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
18.52
+1.34 (7.80%)
At close: Aug 1, 2025, 4:00 PM
18.53
+0.01 (0.05%)
After-hours: Aug 1, 2025, 7:28 PM EDT
Revance Therapeutics Market Cap
Fulgent Genetics has a market cap or net worth of $563.82 million as of August 1, 2025. Its market cap has decreased by -13.84% in one year.
Market Cap
563.82M
Enterprise Value
-212.80M
1-Year Change
-13.84%
Ranking
Category
Stock Price
$18.52
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $563.82M, an increase of 260.27%. That is a compound annual growth rate of 15.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 523.00M | -7.42% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
| Sep 29, 2016 | 156.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |